FindTrial
Sign In

Complication of bleeding after pancreaticoduodenectomy in treatment periampullary cancer

Complication of bleeding after pancreaticoduodenectomy in treatment periampullary cancer and the risk fators: a multicenter study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210826005
Enrollment
145
Registered
2021-08-26
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who are diagnosed with periampullary cancer Bleeding Pancreaticoduodenectomy Periampullary cancer

Interventions

The patient with periampullary cancer in both centers (University of Medicine and Pharmacy Center and Cho Ray Hospital) will be consulted to participate in the study
Prevention
Periampullary cancer

Sponsors

Cho Ray Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patient who is diagnosed with periampullary cancer The postoperative pathology are carcinoma of pancreas, duodenum, distal common bile duct, ampullary

Exclusion criteria

Exclusion criteria: The patient refuse to participate in the study

Design outcomes

Primary

MeasureTime frame
Early bleeding Within 24 hours after pancreaticoduodenectomy Blood in abdominal drainage's fluid—

Secondary

MeasureTime frame
Delay bleeding Within 7 days after pancreaticoduodenectomy Blood in nasal gastro tube or abdominal drainage's fluid—

Countries

Vietnam

Contacts

Public ContactVo Quoc

University of Medicine and Pharmacy at Ho Chi Minh City

bsvotruongquoc@ump.edu0364662378

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026